Physician profile
Faheem Nusrat
NPI 1235121237
$7,948.82
in general payments reported to CMS, 2019-2025
44 companies · $1,858 in 2025
The $1,858 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,035 · 2020: $455 · 2021: $701 · 2022: $540 · 2023: $1,414 · 2024: $1,946 · 2025: $1,858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,217 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,217.36 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,224.83 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $871.34 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $866.92 | 2019-2025 | |
| Abbvie INC. | $715.66 | 2021-2025 | |
| Novo Nordisk INC | $668.09 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Glaxosmithkline, LLC. | $529.18 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Novartis Pharmaceuticals Corporation | $393.07 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $320.16 | 2019-2025 | Jardiance, Synjardy |
| Exact Sciences Corporation | $239.76 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Amgen INC. | $225.78 | 2019-2025 | Repatha, Otezla, Repatha |
| Sanofi-Aventis U.S. LLC | $175.51 | 2019-2025 | |
| Allergan, INC. | $134.44 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $131.14 | 2021-2025 | Linzess |
| Amarin Pharma, INC. | $122.89 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $122.09 | 2021-2025 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faheem Nusrat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.